Australian government identifies medical manufacturing priorities

1 October 2020

The Australian government today announced a A$1.3 billion ($915 million) Modern Manufacturing Initiative (MMI) and the National Manufacturing Priorities.

The $1.3 billion MMI will drive lasting change for Australian manufacturers. It will help Australian manufacturers: scale-up; collaborate; and commercialize. It will unlock private sector investment and support manufacturers to deliver on the world stage, it was emphasized.

"The objective is to build scale and capture income in high value areas of manufacturing where Australia either has established competitive strength or emerging priorities," Prime Minister Scott Morrison said, during his pre-budget speech at the National Press Club on Thursday.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK